Covered recipient · General Payments record
MANINDER PABLA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,112.57
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.54 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $120.45 | 5 |
| Radius Health, Inc. | $32.35 | 1 |
| Novo Nordisk AS | $30.36 | 2 |
| PFIZER INC. | $15.63 | 1 |
| Acerta Pharma LLC | $15.57 | 1 |
| Lilly USA, LLC | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.02 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166644 | CMS |
| ABBVIE INC. | $18.47 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166646 | CMS |
| ABBVIE INC. | $29.68 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166648 | CMS |
| ABBVIE INC. | $18.60 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166650 | CMS |
| ABBVIE INC. | $22.68 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166652 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.57 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105757309 | CMS |
| Lilly USA, LLC | $13.18 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148190 | CMS |
| Novo Nordisk Inc | $17.25 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096606835 | CMS |
| Novo Nordisk Inc | $13.11 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096877024 | CMS |
| PFIZER INC. | $15.63 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131746716 | CMS |
| Radius Health, Inc. | $32.35 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089971533 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.